https://www.panabee.com/news/protagonist-therapeutics-forges-ahead-icotrokinra-nda-filed-rusfertide-imminent-and-cash
Protagonist Therapeutics Forges Ahead: Icotrokinra NDA Filed, Rusfertide Imminent, and Cash Secured...
Protagonist Therapeutics reached significant milestones, filing an NDA for icotrokinra in psoriasis and preparing for rusfertide's NDA submission later this...
https://www.novumpr.nl/2025/12/06/protagonist-and-takeda-present-longer-term-data-at-ash-2025-showing-rusfertide-delivers-durable-response-and-hematocrit-control-in-polycythemia-vera/
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable...